Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation

References

• BreivikHCollettBVentafriddaVCohenRGallacherDSurvey of chronic pain in Europe: prevalence, impact on daily life, and treatmentEur J Pain200610428733316095934
   PubMed Web of Science ®Google Scholar
• AbdullaAAdamsNBoneMBritish Geriatric SocietyGuidance on the management of pain in older peopleAge Ageing201342suppl 1i1i5723420266
   PubMed Web of Science ®Google Scholar
• ChaiEHortonJRManaging pain in the elderly population: pearls and pitfallsCurr Pain Headache Rep20101440941720878270
   PubMed Web of Science ®Google Scholar
• FredheimOMKaasaSFayersPSaltnesTJordhøyMBorchgrevinkPChronic non-malignant pain patients report as poor health-related quality of life as palliative cancer patientsActa Anaesthesiol Scand20085214314818005378
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older PersonsPharmacological management of persistent pain in older personsJ Am Geriatr Soc2009571331134619573219
   PubMed Web of Science ®Google Scholar
• ChouRFanciulloGJFinePGClinical guidelines for the use of chronic opioid therapy in chronic noncancer painJ Pain200910211313019187889
   PubMed Web of Science ®Google Scholar
• GianniWMadaioRADi CioccioLPrevalence of pain in elderly hospitalized patientsArch Gerontol Geriatr20105127327620031238
   PubMed Web of Science ®Google Scholar
• RianonNKnellMEAgbor-BawaWThelenJBurkhardtCRasuRSPersistent non-malignant pain management using nonsteroidal anti-inflammatory drugs in older patients and use of inappropriate adjuvant medicationsDrug Healthc Patient Saf20157435025678818
   PubMedGoogle Scholar
• KahanMSrivastavaAWilsonLMailis-GagnonLMidmerDOpioids for managing chronic non-malignant pain: safe and effective prescribingCan Fam Physician2006521091109617279219
   PubMed Web of Science ®Google Scholar
• VestergaardPRejnmarkLMosekildeLFracture risk associated with the use of morphine and opiatesJ Intern Med20062601768716789982
   PubMed Web of Science ®Google Scholar
• ThorellKRanstadKMidlövPBorgquistLHallingAIs use of fall risk-increasing drugs in an elderly population associated with an increased risk of hip fracture, after adjustment for multimorbidity level: a cohort studyBMC Geriatr20141413125475854
   PubMed Web of Science ®Google Scholar
• KurzASesslerDIOpioid-induced bowel dysfunction: pathophysiology and potential new therapiesDrugs20036364967112656645
   PubMed Web of Science ®Google Scholar
• BellTJPanchalSJMiaskowskiCBolgeSCMilanovaTWilliamsonRThe prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)Pain Med200910354218721170
   PubMed Web of Science ®Google Scholar
• NelsonADCamilleriMChronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunitiesTherap Adv Gastroenterol201584206220
   PubMed Web of Science ®Google Scholar
• WanYCormanSGaoXLiuSPatelHModyREconomic burden of opioid-induced constipation among long-term opioid users with noncancer painAm Health Drug Benefits2015829310226005516
   PubMedGoogle Scholar
• MeissnerWLeyendeckerPMueller-LissnerSA randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipationEur J Pain200913566418762438
   PubMed Web of Science ®Google Scholar
• SimpsonKLeyendeckerPHoppMFixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate to severe noncancer painCurr Med Res Opin200824123503351219032132
   PubMed Web of Science ®Google Scholar
• LöwensteinOLeyendeckerPHoppMCombined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant pain: a randomised controlled trialExpert Opin Pharmacother200910453154319243306
   PubMed Web of Science ®Google Scholar
• GattiACasaliMLazzariMProlonged-release oxycodone/naloxone in nonmalignant pain: single-center study in patients with constipationAdv Ther2013301415923269562
   PubMed Web of Science ®Google Scholar
• GuerrieroFSgarlataCMarcassaCRicevutiGRolloneMEfficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patientsClin Interv Aging20141011125565782
   PubMed Web of Science ®Google Scholar
• HesselbarthSHermannsKOepenPProlonged-release oxycodone/naloxone in opioid-naïve patients – subgroup analysis of a prospective observational studyExpert Opin Pharmacother201516445746425612469
   PubMed Web of Science ®Google Scholar
• World Health Organization [webpage on the Internet]Cancer Pain Relief2nd edGeneva1996 Available from: http://apps.who.int/iris/bitstream/10665/37896/1/9241544821.pdfAccessed January 11, 2016
   Google Scholar
• Summary of Product Characteristics [webpage on the Internet]Targin 5/2.5 mg, 10/5 mg, 20/10 mg and 40/20 mg Prolonged Release Tablets2015 Available from: http://www.medicines.ie/medicine/14383/SPC/Targin+5+2.5mg%2c+10mg+5mg%2c+20mg+10mg+and+40+20mg+prolonged+release+tablets/Accessed February 28, 2016
   Google Scholar
• RentzAMYuRMüller-LissnerSLeyendeckerPValidation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipationJ Med Econ20091237138319912069
   PubMedGoogle Scholar
• SchutterUGrunertSMeyerCSchmidtTNolteTInnovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practiceCurr Med Res Opin20102661377138720380506
   PubMed Web of Science ®Google Scholar
• BlagdenMHaferJDuerrHHoppMBosseBLong-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trialsNeurogastroenterol Motil201426121792180125346155
   PubMed Web of Science ®Google Scholar
• AhmedzaiSHLeppertWJaneckiMLong-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer painSupport Care Cancer201523382383025218610
   PubMed Web of Science ®Google Scholar
• MaltoniMScarpiEModonesiCA validation study of the WHO analgesic ladder: a two-step vs three-step strategySupport Care Cancer20051388889415818486
   PubMed Web of Science ®Google Scholar
• FurlanADSandovalJAMailis-GagnonATunksEOpioids for chronic noncancer pain: a meta-analysis of effectiveness and side effectsCMAJ20061741589159416717269
   PubMed Web of Science ®Google Scholar
• NatoliSLazzariMDauriMOpen questions in the treatment of cancer pain: time for a strong evidence-based approach?Expert Opin Pharmacother20151611425387541
   PubMed Web of Science ®Google Scholar
• European Medicines Agency [webpage on the Internet]Restrictions on the Use of Codeine for Pain Relief in Children – CMDh Endorses PRAC Recommendation2013 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/06/WC500144851.pdfAccessed January 11, 2016
   Google Scholar
• BarberJBGibsonSJTreatment of chronic non-malignant pain in the elderly: safety considerationsDrug Safety20093245747419459714
   PubMed Web of Science ®Google Scholar
• ParkSHWackernahRCStimmelGLSerotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants?J Pharm Pract2014271717824153222
   PubMedGoogle Scholar
• HolzerPOpioid receptors in the gastrointestinal tractRegul Pept20091551–3111719345246
   PubMed Web of Science ®Google Scholar
• CheyWWebsterLSostekMLappalainenJBarkerPTackJNaloxegol for opioid-induced constipation in patients with noncancer painN Engl J Med20143702387239624896818
   PubMed Web of Science ®Google Scholar